K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 335.4 INR 0.77% Market Closed
Market Cap: 5.9B INR

Kilitch Drugs (India) Ltd
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kilitch Drugs (India) Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Gross Profit
₹747.8m
CAGR 3-Years
16%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Gross Profit
₹229.5B
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
14%
Cipla Ltd
NSE:CIPLA
Gross Profit
₹192.3B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Gross Profit
₹437.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
8%
Lupin Ltd
NSE:LUPIN
Gross Profit
₹177.5B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Gross Profit
₹92.7B
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
8%
No Stocks Found

Kilitch Drugs (India) Ltd
Glance View

Market Cap
5.5B INR
Industry
Pharmaceuticals

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

KILITCH Intrinsic Value
329.45 INR
Overvaluation 2%
Intrinsic Value
Price
K

See Also

What is Kilitch Drugs (India) Ltd's Gross Profit?
Gross Profit
747.8m INR

Based on the financial report for Jun 30, 2025, Kilitch Drugs (India) Ltd's Gross Profit amounts to 747.8m INR.

What is Kilitch Drugs (India) Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
31%

Over the last year, the Gross Profit growth was 34%. The average annual Gross Profit growth rates for Kilitch Drugs (India) Ltd have been 16% over the past three years , 31% over the past five years .

Back to Top